{
    "root": "24b83701-502d-43cc-8ea3-9fc7e3e342d5",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Triamcinolone Acetonide",
    "value": "20250129",
    "ingredients": [
        {
            "name": "TRIAMCINOLONE ACETONIDE",
            "code": "F446C597KA"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM",
            "code": "K679OBS311"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "NITROGEN",
            "code": "N762921K75"
        }
    ],
    "indications": null,
    "contraindications": null,
    "warningsAndPrecautions": "triamcinolone acetonide injectable suspension , usp supplied vials providing 40 mg triamcinolone acetonide per ml packaged carton containing 25 vials . ndc 0143-9387-01 : 40 mg/ml , 1 ml single-dose vial ndc 0143-9387-25 : 40 mg/ml , 25 single-dose vials 1 carton storage store 20°c 25°c ( 68°f 77°f ) [ usp controlled room temperature ] ; protect temperatures 20°c ( 68°f ) . excursions permitted 15ºc 30ºc ( 59ºf 86ºf ) store vial carton protect light . refrigerate . store vial upright . : chemical physical in-use stability demonstrated 28 days 25ºc ( 77ºf ) . microbiological point view , opened , product may stored maximum 28 days 15ºc 25ºc ( 59ºf 77ºf ) . in-use storage times conditions responsibility user . report suspected , contact hikma pharmaceuticals usa inc. 1-877-845-0689 , fda 1-800-fda-1088 www.fda.gov/medwatch . product inquiry call 1-877-845-0689. manufactured : hikma farmacêutica ( portugal ) , s.a. estrada rio da mó , 8 , 8a e 8b – fervença – 2705-906 terrugem snt , portugal distributed : hikma pharmaceuticals usa inc. berkeley heights , nj 07922 november 2024 pin575-wes/4",
    "adverseReactions": "triamcinolone acetonide injectable suspension contraindicated patients hypersensitive components product ( : general ) . intramuscular corticosteroid preparations contraindicated idiopathic thrombocytopenic purpura .",
    "warningsAndPrecautions_original": "Triamcinolone Acetonide Injectable Suspension, USP is supplied in vials providing 40 mg triamcinolone acetonide per mL and packaged in a carton containing 25 vials.\n                  NDC 0143-9387-01: 40 mg/mL, 1 mL single-dose vial\n                  NDC 0143-9387-25: 40 mg/mL, 25 single-dose vials in 1 carton\n                  \n                     Storage\n                  \n                  \n                     Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]; protect from temperatures below 20°C (68°F). Excursions are permitted between 15ºC and 30ºC (59ºF and 86ºF) Store vial in carton to protect from light. Do not refrigerate. Store vial upright.\n                  Once in use: Chemical and physical in-use stability has been demonstrated for 28 days below 25ºC (77ºF).\n                  From a microbiological point of view, once opened, the product may be stored for a maximum of 28 days 15ºC and 25ºC (59ºF and 77ºF). Other in-use storage times and conditions are the responsibility of the user.\n                  To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. \n                  For Product Inquiry call 1-877-845-0689.\n                  \n                     Manufactured by:\n                  \n                  HIKMA FARMACÊUTICA (PORTUGAL), S.A.\n                  Estrada do Rio da Mó, 8, 8A e 8B – Fervença – 2705-906 Terrugem SNT, PORTUGAL\n                  \n                     Distributed by:\n                  \n                  Hikma Pharmaceuticals USA Inc. \n                  Berkeley Heights, NJ 07922\n                  November 2024                                                                                           PIN575-WES/4",
    "adverseReactions_original": "Triamcinolone acetonide injectable suspension is contraindicated in patients who are hypersensitive to any components of this product (see \n                        WARNINGS: General\n                     ).\n                  Intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura."
}